Skip to main content
. 2015 Jan 12;21:144–152. doi: 10.12659/MSM.892405

Figure 4.

Figure 4

In the surgery group, the 1- and 3-year OS were 68% and 15% in patients with controlled primary tumors, and 50% and 13% in the other patients with uncontrolled primary tumors. The 5-year OS was up to 21% in patients with controlled primary tumors.